Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Suhena Sarkar"'
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 17, Iss 12, Pp 01-06 (2023)
Introduction: Self-medication is an important health issue. The rising tendency of self-medication has been a cause for concern. Rheumatic patients, being vulnerable to various symptoms like pain and fever, may resort to self-medication. Although
Externí odkaz:
https://doaj.org/article/a51d3911dbba4bc59de661b618871c86
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 15, Iss 3, Pp FC05-FC09 (2021)
Introduction: Selective Serotonin Reuptake Inhibitors (SSRIs) are recommended as first-line anti-depressants in Major Depressive Disorder (MDD) because of their relatively benign safety profile. Hyponatremia is under reported and notorious advers
Externí odkaz:
https://doaj.org/article/70ea37c80dd940db9465eb296c93888c
Publikováno v:
INDIAN JOURNAL OF APPLIED RESEARCH. :31-33
Autor:
Nitu Mallik Dr, Sidhartha Bhatrtacharya Dr, Lekha Biswas Dr, Prajna Sarkar Dr, Suhena Sarkar Dr, Aritra Pal
Publikováno v:
INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH. :17-20
INTRODUCTION:Selective serotonin reuptake inhibitors (SSRIs) are a class of drugs that selectively increase the levels of serotonin in the synaptic cleft by blocking its uptake by serotoninergic neurons. They are now extensively used to treat various
Publikováno v:
National Journal of Physiology, Pharmacy and Pharmacology. :1
Background: There is an increased use of antidepressant and anti-anxiety medications as an aftermath of unfavorable conditions such as the COVID-19 pandemic. There is a need to estimate its use during this period. Aims and Objectives: This study will
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 15, Iss 3, Pp FC05-FC09 (2021)
Introduction: Selective Serotonin Reuptake Inhibitors (SSRIs) are recommended as first-line anti-depressants in Major Depressive Disorder (MDD) because of their relatively benign safety profile. Hyponatremia is under reported and notorious adverse ef